WEB瘤内治疗(WEB intrasaccular therapy,WEBIT)研究是FDA批准前进行的有关装置安全性和有效性的多中心前瞻性研究,共纳入使用WEB治疗的颅内动脉分叉部宽颈动脉瘤患者150 例,1 年观察期内主要卒中事件发生率小于1.0% ,无患者死亡｡该研究显示动脉瘤闭塞率为84. 6% (121 / 143 ...

2012年3月23日 · Intrasaccular flow disruption is a new endovascular approach for aneurysm treatment, aiming at disrupting the intra-aneurysmal flow and creating intra-aneurysmal thrombosis by using a device to close the aneurysm neck from inside the aneurysm.

Introduction: The Woven EndoBridge (WEB) represents a novel intrasaccular therapeutic option for the treatment of intracranial wide-necked bifurcation aneurysms (WNBAs). The WEB-IT Study is a pivotal Investigational Device Exemption (IDE) study to determine the safety and effectiveness of the WEB device for the treatment of WNBAs located in the ...

2024年10月16日 · Results: Intrasaccular devices have proven to be effective in treating complex aneurysms like WNAs. Conclusions: Intrasaccular flow disruptors have emerged as a new class of effective endovascular therapy, and results of ongoing clinical studies for the newer devices (e.g., SEAL and Trenza) are much anticipated.

Introduction: The Woven EndoBridge Intrasaccular Therapy (WEB-IT) Study is a pivotal, prospective, single-arm, investigational device exemption study designed to evaluate the safety and effectiveness of the WEB device for the treatment of wide-neck bifurcation aneurysms.

Introduction: The WEB Intra-saccular Therapy (WEB-IT) trial is an investigational device exemption study to demonstrate the safety and effectiveness of the WEB device for the treatment of wide-neck bifurcation aneurysms. The neurovascular replicator (Vascular Simulations, Stony Brook, New York, USA) creates a physical environment that ...

2023年4月1日 · During the past 10 years, the intrasaccular Woven EndoBridge (WEB; MicroVention) device has completely changed endovascular treatment (EVT) of wide-neck intracranial aneurysms (IAs).

2023年9月3日 · 现病史： 患者于入院前6个月无诱因出现头晕，于外院就诊，行头部CTA检查示前交通动脉瘤，病程中无视物旋转、复视、肢体麻木无力、意识障碍。 为求明确诊治遂来我院，门诊以“颅内动脉瘤”收入我科，发病以来，睡眠欠佳，饮食尚可，二便正常。 既往史： 食管平滑肌瘤5年，耳石症6个月，否认高血压、糖尿病、心脏病史，否认肝炎、结核、梅毒病史，否认外伤、手术史，否认烟酒史。 查体： 神志清醒，言语流利，眼球运动自如，无眼震，双侧瞳孔等大等 …

本文介绍颅内动脉瘤血管内治疗中的瘤内扰流装置，如WEB、Medina等多种装置。 阐述其结构、临床应用情况等。 瘤内扰流装置有助于解决抗血小板治疗顾虑。

2024年1月25日 · Endovascular therapy for unruptured saccular ICAs has benefited from the emergence of novel technology in the last decade. Intrasaccular and extrasaccular flow diverters are some of the most notable technologies for the treatment of a wide array of ICA geometries, rupture status, and anatomic location.